On Nov. 28, 2025, the United States Patent and Trademark Office (USPTO) issued new examination guidance clarifying inventorship standards for artificial intelligence (AI)-assisted inventions. This update rescinds the prior...more
In September 2025, the Food and Drug Administration (FDA) issued three draft guidance documents designed to facilitate the continued development of novel cell and gene therapies. The recommendations include guidance regarding...more